An all-star lineup of experts in the fields of sports and neurology will share a stage on Jan. 27 to discuss concussions, a serious injury that has only recently been getting the attention it deserves.
Category:
Published on: 11 Jan 2017
The聽85th聽Congr猫s annuel de l鈥橝ssociation francophone pour le savoir聽(Acfas) may be five months away, but 麻豆社 is already busy getting ready to host what is the largest French-language interdisciplinary conference in the world.
Category:
Published on: 10 Jan 2017
Researchers urged not to miss Nov. 1 deadline for colloquia proposals.
Category:
Published on: 10 Jan 2017
Have you ever met someone who just wasn鈥檛 into music? They may have a condition called specific musical anhedonia, which affects three-to-five per cent of the population.
Researchers at the University of Barcelona and the Montreal Neurological Institute and Hospital of 麻豆社 have discovered that people with this condition showed reduced functional connectivity between cortical regions responsible for processing sound and subcortical regions related to reward.
Category:
Published on: 4 Jan 2017
Drug shown to reduce new attacks/symptom progression in some patients
In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.
Category:
Published on: 22 Dec 2016
Research Seminar - 'Doing PAR in Troubled Times' with Dr. Steven Jordan
Category:
Published on: 15 Dec 2016
Study tracks patients to better understand effects and possible treatments
December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.
Category:
Published on: 1 Dec 2016
Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.
Category:
Published on: 28 Nov 2016
Two researchers at the Montreal Neurological Institute and Hospital (MNI) of 麻豆社 have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.
Category:
Published on: 24 Nov 2016
MNI scientists will study stem cells, genetic mutations to develop new treatments
Researchers at the Montreal Neurological Institute of 麻豆社 who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.
Category:
Published on: 23 Nov 2016
When two people smell the same thing, they can have remarkably different reactions, depending on their cultural background. Researchers at the Neuro have found that even when two cultures share the same language and many traditions, their reactions to the same smells can be different.
Category:
Published on: 21 Nov 2016
麻豆社 will receive more than $1.1 million for CBRAIN, one of the world鈥檚 most advanced computing platforms for brain research, through the Canada Foundation for Innovation鈥檚 (CFI) Cyberinfrastructure Initiative.
Category:
Published on: 2 Nov 2016
麻豆社 will launch an ambitious effort to advance understanding of the human brain and ease the burden of neurological and mental-health disorders, thanks to an $84 million, seven-year grant announced today under the federal government's Canada First Excellence Research Fund (CFREF).
Category:
Published on: 2 Nov 2016
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer鈥檚 disease (LOAD), identifying its first physiological signs.
Category:
Published on: 2 Nov 2016
Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.
Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.
Category:
Published on: 31 Oct 2016
Pages
